Colorado BioScience Association News Feed

Aurora Sentinel: 'Victories for CID4 a victory for Colorado bioscience industry, too'

noreply@blogger.com (Maggie Chamberlin Holben, APR) — Mon, 13 Feb 2012 20:27:00 +0000

Quoting from the January 26th article by Brandon Johansson:

"The organization, which stands for Colorado Institute for Drug, Device and Diagnostic Development, helped Sophono get its start, providing some initial investment capital that helped Sophono get off the ground. Last year’s jobs announcement from Sophono was part of 16 new, direct jobs created in the first quarter of 2011 by a company affiliated with CID4, according to CID4’s annual metric report released last month...

Kevin Smith, the organization’s CEO, said in terms of direct jobs, that proved to be CID4’s biggest quarter since the organization got its start in 2009...

Smith said that in the case of PeptiVir, a company working to develop an influenza vaccine, the CID4 investment helped the company to leverage the state for an additional grant.

'It was a perfect example,' he said.

Holli Riebel, CEO of the Colorado Bioscience Association, said in situations like that, CID4 has played an important role for bioscience companies.

When those companies get their start, they often don’t have the finances necessary to test their product, let alone take it to market, she said. CID4 provides the initial capital that companies need to help them seek other forms of investment, including government grants.

'Every little bit moves along to the next stage and makes them more attractive to bigger donors,' she said."

Link to the article

NCBR: 'Report: Colorado patent office would create jobs'

noreply@blogger.com (Maggie Chamberlin Holben, APR) — Fri, 03 Feb 2012 19:22:00 +0000

Quoting from the Jan 31 Northern Colorado Business Report posting:

"The effort to locate the patent office in Colorado has drawn broad support following an amendment sponsored by Bennet and U.S. Sen. Mark Udall that allows the Patent and Trademark Office to establish three new offices nationwide during the next three years.

'A satellite patent office in Colorado would help our bioscience sector get patents approved more efficiently and help bring life-saving technology and medicines to patients more quickly and safely,' Holli Reibel, president and CEO of the Colorado BioScience Association, said in a statement issued by Bennet's office.

Northern Colorado businesses were among the organizations that wrote letters supporting the satellite patent office."

Link to the article

PoliticalNews: 'Colorado Business Leaders Unveil New Report Making the Case for Patent Office in Denver '

noreply@blogger.com (Maggie Chamberlin Holben, APR) — Fri, 03 Feb 2012 19:18:00 +0000

Quoting CBSA's Holli Riebel from the February 1 article:

"'A satellite patent office in Colorado would help our bioscience sector get patents approved more efficiently and help bring life-saving technology and medicines to patients more quickly and safely,' said Holli Reibel, president and CEO of the Colorado BioScience Association. 'It’s great to see a coordinated, comprehensive effort among stakeholders to bring a satellite patent office to Colorado.'"

Link to Political News

Denver Post: 'BioScience group to hold day at the capitol'

noreply@blogger.com (Maggie Chamberlin Holben, APR) — Fri, 03 Feb 2012 19:10:00 +0000

Quoting from Margaret Jackson's January 31st blog posting:

"The Colorado BioScience Association is hosting BioScience Day at the Capitol from 7:30 to 9 a.m. [Thursday] at the Legislative Services Building A at 14th and Sherman.

During the event, legislators will discuss the 2012 session and their vision for the bioscience industry."

Link to denverpost.com

Denver Post: 'Colorado in running for U.S. patent satellite office'

noreply@blogger.com (Maggie Chamberlin Holben, APR) — Tue, 31 Jan 2012 16:08:00 +0000

Quoting from today's Denver Post article by Allison Sherry - @allisonsherry - on the 'Bring A Patent Office To Colorado' initiative:

"Holli Riebel, president of the Colorado BioScience Association, helped marshal signatures and support within her field for the office.

'Many times, things go to the coasts and they don't go to the middle of the country,' she said. 'I think there's a huge market that could be drawn from the middle. It's an easy place for everyone to get to, and we do have an international airport.'"

Link to the Denver Post article

View the related video:
http://youtu.be/xKW6j33EipQ

Link to the news release: 'Colorado Business Leaders Unveil New Report Making the Case for Patent Office in Denver'

This Thursday: Colorado's 'BioScience Day at the Capitol'

noreply@blogger.com (Maggie Chamberlin Holben, APR) — Mon, 30 Jan 2012 22:31:00 +0000

Colorado BioScience Association will host the fourth annual “BioScience Day at the Capitol” on Thursday, February 2nd, 7:30-9:00 a.m. at the Legislative Services Building, A, 14th & Sherman (South side of Capitol). The event will bring together industry leaders and legislators to support the growth of bioscience in Colorado.

Agenda for BioScience Day at the Capitol:

* 8:00-8:10 a.m. – Welcome by Holli Riebel, President and CEO, CBSA

* 8:10-8:40 a.m. – Legislators discuss the 2012 session and their vision for the bioscience industry

Representative Cheri Gerou - Overview of the 2012 Budget
Speaker of the House, Representative Frank McNulty
Senate President Brandon Shaffer

* 8:40-9:00 a.m. – Federal Legislation Presentation by Jason Sapsin, Polsinelli Shughart

This year CBSA will build upon one of its most successful years in its history, making impressive strides in the areas of industry advocacy, programming, marketing communications, membership and education. CBSA was instrumental in the development and passage of House Bill 1283 and Senate Bill 47 retaining and further funding Colorado's Bioscience Discovery Evaluation Grant Program. Other legislative success included passing of Senate Bill 159, distribution of the state's share of limited gaming revenue.

Link to the Business Wire release

Link to the PitchEngine social media release

CBSA January FOCUS Newsletter: Featuring Fitzsimons Bioscience Park's $8 Million Expansion and a Sneak Peek at CBSA's Plans for the Upcoming Year

noreply@blogger.com (Maggie Chamberlin Holben, APR) — Sat, 28 Jan 2012 18:13:00 +0000

Quoting CBSA President & CEO Holli Riebel:

"As we kick off the New Year at CBSA we are thankful for a great 2011 and look forward to the opportunities that lie ahead in 2012. Our community's spirit of innovation and history of success continues to push the bioscience industry forward. CBSA's strategic goals for the year are to:

* Promote a supportive regulatory and tax environment at the state and federal level.
* Increase access to capital.
* Brand Colorado's innovation in the bioscience industry.
* Enhance programs and services for our members.
* Create a bioscience community that fosters growth.

A feature detailing the $8 million expansion of the Fitzsimons Bioscience Park is on page 2.

Link to the January FOCUS newsletter

Denver Business Journal: 'VC-backed startups now free to chase SBIR grant money'

noreply@blogger.com (Maggie Chamberlin Holben, APR) — Sun, 15 Jan 2012 16:10:00 +0000

Quoting CBSA board members Mark Spiecker and Rick Duke in Greg Avery's article:

"The change will be particularly helpful to many early-stage bioscience companies in Colorado, making them eligible for a program that’s awarded $16 billion in grants since 1997.

'Everybody’s writing SBIR grants or counting on them in one way or another,' said Mark Spiecker, co-founder of Sharklet Technologies.

The Aurora-based startup has survived on SBIR grants that pay for its research into a bacteria-fighting surface coating for medical uses, a technology inspired by the bacteria-fighting properties of shark skin. But that meant limiting the involvement of VC investors.

Sharklet landed $1.2 million in SBIR grants in early 2011. Without them, the company would have shut down, Spiecker said. Sharklet’s pursuing more SBIR grants under the new rules...

...For more established biotechs, the old SBIR ban limited their ability to research new uses for their technologies, said Rick Duke, a veteran biotech entrepreneur who helps run the Colorado Institute for Drug, Device and Diagnostic Development (CID4), a nonprofit incubator for biotech companies.

Now a biotech can use for SBIR grants for research to broaden the number of products the company’s developing, while investors fund getting the first product to market. That should help companies grow faster and be stronger, and speed the development of new medicines.

'It’s helpful from the point of view of continuing to be innovative among companies that are funded with venture capital,' Duke said."

Link to the article that also quoted Cartier Esham, BIO’s senior director on health regulations for emerging companies (subscription required for full article access)

GEN: 'Cities are trying to attract more talent and incentives to meet demands of the life science industry."

noreply@blogger.com (Maggie Chamberlin Holben, APR) — Thu, 05 Jan 2012 12:40:00 +0000

Quoting from the January 3rd article by Alex Philippidis:

"Denver anchors a growing Colorado biopharma effort that will see the state divert part of the corporate sales taxes collected from biotech and cleantech companies between 2013 and 2023 to help fund startups in those industries under a law enacted in May by Gov. John Hickenlooper (D). Bio startups also saw welcome news earlier this month when the Fitzsimmons Redevelopment Authority announced plans for an $8 million, 37,000 sq. ft. “accelerator” space within its Bioscience Park for companies past the incubator stage."

Link to GEN

Coloradoan: 'CSU chemistry prof honored by CBSA'

noreply@blogger.com (Maggie Chamberlin Holben, APR) — Thu, 05 Jan 2012 12:23:00 +0000

Quoting from the December 13th news brief:

"The Colorado Bioscience Association recently recognized Melissa Reynolds, assistant chemistry professor, as Educator of the Year.

This is Reynolds' second major award in the past year. In 2010, the Boettcher Foundation named Reynolds as one of only six inaugural Boettcher Investigators as part of the Webb-Waring Biomedical Research Pro-gram, which helps recruit, retain and advance scientific talent in Colorado. She was the only one from Colorado State named that year."

Link to the Coloradoan

2011 Boettcher Investigators Introduced to Colorado Bioscience Community

noreply@blogger.com (Maggie Chamberlin Holben, APR) — Tue, 13 Dec 2011 13:59:00 +0000

The 2011 class of Boettcher Investigators was introduced to Colorado's Bioscience Community at the Colorado BioScience Association's Annual Awards Dinner celebration, December 8, in Denver. Timothy Schulz, Boettcher Foundation Executive Director, made the presentation, along with Ted White, chair of the Boettcher Foundation Board of Trustees.

The 2011 Boettcher Investigators include: Tingting, Yao, Ph.D., Colorado State University; Zhe Chen, Ph.D., University of Colorado Boulder; Jing Wang, M.D., Ph.D., University of Colorado Anschutz Medical Campus; Robert Doebele, M.D., Ph.D., University of Colorado Anschutz Medical Campus; and John D. (Nick) Fisk, Ph.D., Colorado State University. Video of the presentation follows:

http://youtu.be/ub8azy2KG8M

Reminder This Week: BioBeers Denver 4Q11 | Holiday Party Edition!

noreply@blogger.com (Maggie Chamberlin Holben, APR) — Tue, 13 Dec 2011 12:54:00 +0000

Come celebrate the holiday season at Fitzsimons with friends old and new in BioBeers style! We'll be serving up the eggnog and celebrating so many important milestones met by our life science ecosystem in 2011 and looking ahead to what is certain to be an exciting 2012!

Thursday, December 15, 2011, 6:00 PM

Bioscience Park Center Lobby - Fitzsimons

12635 East Montview Blvd. , Aurora, CO

Link to RSVP

Site Selection: 'Colorado Bio has solid infrastructure'

noreply@blogger.com (Maggie Chamberlin Holben, APR) — Mon, 12 Dec 2011 20:54:00 +0000

Quoting from the recent bylined article by CBSA President & CEO Holli Riebel:

"Colorado is the next frontier in life sciences. Every day, more than 600 Colorado bioscience companies help improve lives locally and around the world. The state has seen its bioscience industry continue to grow faster than the national average over the past five years with more than 20,000 employees, and in fact grew 1.8 percent last year when the rest of the country saw a 2.4 percent decline. Colorado ranks sixth in medical device employment and houses medical device and biotechnology companies such as Caridian BCT, Covidien, Baxa, Amgen, Merck, and Roche."

The article details the top benefits to locating a bioscience company in Colorado

Link to read the full article

CSU News & Information: 'Colorado Bioscience Association Names Colorado State University Chemistry Professor Educator of the Year'

noreply@blogger.com (Maggie Chamberlin Holben, APR) — Sat, 10 Dec 2011 19:49:00 +0000

Quoting from the CSU News website:

"The Colorado Bioscience Association on Thursday night recognized Melissa Reynolds, assistant chemistry professor at Colorado State University, as Educator of the Year.

Reynolds was honored along with U.S. Sen. Michael Bennet, state Rep. Cheri Gerou and Ernst & Young, among others.This is her second major award in the past year. In 2010, the Boettcher Foundation named Reynolds as one of only six inaugural Boettcher Investigators as part of the Webb-Waring Biomedical Research Program, which helps recruit, retain and advance scientific talent in Colorado. She was the only one from Colorado State named that year.

The Colorado Bioscience Association acknowledged Reynolds, a 2010 Boettcher Investigator, with this most recent honor because 'in addition to teaching graduate and undergraduate courses, she has organized professional development and entrepreneurship programs and mentored over 25 multidisciplinary students. Her positive leadership and encouragement has been continually evident to her colleagues, funders and the bioscience community as a whole.'"

Link to CSU News & Information

NCBR: 'Colorado Bioscience Association selects two from Northern Colorado'

noreply@blogger.com (Maggie Chamberlin Holben, APR) — Sat, 10 Dec 2011 19:44:00 +0000

Quoting from the Northern Colorado Business Report:

"The Colorado BioScience Association honored a Colorado State University professor and a Fort Collins-based company working to advance human nutrition and medicine.

Melissa Reynolds, assistant professor of chemistry at CSU, received the CBSA's Educator of the Year award for her work in CSU's School of Biomedical Engineering. Reynolds received a $1.3 million Department of Defense grant earlier this year to develop an artificial wound-healing material for battlefield injuries.

Ventria Bioscience, a manufacturer of bioscience products founded in 1993, received the association's Rising Star of the Year award in recognition of its work in commercializing recombinant proteins from a plant-based manufacturing system."

Link to the NCBR article

DBJ: 'Colorado BioScience Association bestows 2011 awards'

noreply@blogger.com (Maggie Chamberlin Holben, APR) — Sat, 10 Dec 2011 19:37:00 +0000

Quoting from the Denver Business Journal website:

"The Colorado BioScience Association presented its annual awards to recognize outstanding companies and people Thursday night during a dinner event at the Embassy Suites Denver.

The event was emceed by Denver Business Journal Editor Neil Westergaard.

Brian Baldwin and his sons Greg Baldwin and Jeff Baldwin were presented with the Lifetime Achievement Award. Baldwin founded Baxa Corp. of Douglas County in 1975 and his sons have helped lead the company."

Link to the DBJ

Denver Post: 'Colorado bioscience awards announced'

noreply@blogger.com (Maggie Chamberlin Holben, APR) — Sat, 10 Dec 2011 18:46:00 +0000

Quoting from the Denver Post website:

"The Colorado BioScience Association unveiled winners of its 2011 industry awards today. They include:

Brian, Greg and Jeff Baldwin of Baxa Corp., which provides technologies for fluid handling and delivery, are receiving the Life Achievement Award.

LABS Inc., known for its testing work in infectious disease, microbiology, and immunogenetics, is receiving the Company of the Year Award." Plus more...

Link to denverpost.com

Colorado BioScience Association Celebrates 2011 Industry Standouts

noreply@blogger.com (Maggie Chamberlin Holben, APR) — Sat, 10 Dec 2011 17:15:00 +0000

The Colorado BioScience Association (CBSA) honored the outstanding bioscience companies and individuals in the state during its 9th Annual Awards Dinner at the Downtown Denver Embassy Suites. The CBSA's Annual Awards program showcases the significant achievements in the state's bioscience industry throughout the year.

Recipients of 2011 awards include:

Lifetime Achievement Award - Brian, Greg and Jeff Baldwin
Brian Baldwin founded Baxa Corporation in 1975 and grew the company steadily over the succeeding 36 years along with the leadership of sons Greg and Jeff. Creating technology that saves patient lives, Baxa Corporation provides innovative, solution-based technologies for fluid handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of fluid medications. Visit: http://www.baxa.com

Company of the Year - LABS Inc.
LABS, Inc. has grown to service clients across many healthcare industries over the past 30 years. Recently, they added a Cell and Molecular Biology Department to their already growing business. Labs Inc. has been the market leader in laboratory testing for Infectious Disease, Microbiology, and Immunogenetics. Visit: http://www.labs-inc.org

Rising Star of the Year - Ventria Bioscience
Ventria Bioscience is the first company to commercialize recombinant proteins derived from a plant-based manufacturing system. Ventria’s technology platform ExpressTec is a safe, affordable and sustainable manufacturing technology that achieves recombinant protein yield that is many times higher than alternative systems. Visit: http://www.ventria.com

Volunteer of the Year - Timothy Rodell, M.D. President and CEO, GlobeImmune
Timothy Rodell’s leadership and community involvement has greatly contributed to Colorado’s bioscience industry. He contributed significantly to Senator Bennet’s Colorado Competes Report as a member of the Innovation Roundtable. He also has been a voice at the federal level with a seat on BIO’s national Board leading our industry forward. Visit: http://www.globeimmune.com

Educator of the Year - Melissa Reynolds, Ph.D., Assistant Professor of Chemistry, Colorado State University
Melissa Reynolds Ph.D. joined the Colorado State University faculty in 2009 as an Assistant Professor of Chemistry and is a participating faculty member in the School of Biomedical Engineering. In addition to teaching graduate and undergraduate courses she has organized professional development and entrepreneurship programs and mentored over 25 multidisciplinary students. Her positive leadership and encouragement has been continually evident to her colleagues, funders and the bioscience community as a whole. More about Dr. Reynolds: http://www.news.colostate.edu/Release/5620

Business Partner of the Year - Ernst & Young
Ernst & Young has been a strong partner for over seven years helping to move Colorado’s bioscience industry forward. They have provided excellent service to the industry with expertise and dedication to our companies. Visit: http://www.ey.com

Legislator of the Year - State Representative Cheri Gerou
Representative Cheri Gerou has shown continued support for the bioscience community. She was involved in introducing and enabled the passage of HB 1283 and SB 47 to extend and further fund the Bioscience Discovery Evaluation Grant Program. Visit: http://cherigerou.com

Chairman’s Award - Johnson & Johnson
Johnson & Johnson’s dedication to advocacy and strategic development as an industry leader has advanced bioscience in Colorado. The company has continually supported CBSA’s efforts to advance the regional bioscience community including the development of CBSA’s Rocky Mountain Life Science Investor Conference and presence on the Board of Directors. Visit: http://www.jnj.com

Chairman’s Award - U.S. Senator Michael Bennet
Senator Michael Bennet has championed Colorado’s bioscience issues at the Capitol on several major issues including spearheading the Colorado Innovation Economy Committee and the “Colorado Competes” report, of which CBSA co-chaired; a CEO roundtable event with FDA Commissioner Hamburg; and The Medical Device Regulatory Improvement Act, introduced to boost Medical Device innovation and FDA reform. Senator Bennet leadership and perseverance continue to benefit the bioscience community as a whole. Visit: http://bennet.senate.gov

Link to the Business Wire newswire

Aurora Sentinel: 'Fashion photographer Rick Guidotti steps away from supermodel runways to focus on the beauty in being different'

noreply@blogger.com (Maggie Chamberlin Holben, APR) — Fri, 02 Dec 2011 18:26:00 +0000

Aurora Sentinal Staff Writer Sara Castellanos featured CBSA Awards Dinner Keynote Speaker Rick Guidotti today. Quoting from the Sentinel website:

"...A collection of his photographs is being displayed at a gallery in the Santa Fe Arts District in Denver through Dec. 16, and he’ll be the keynote speaker at the Colorado BioScience Association Annual Awards Dinner in Denver on Dec. 8.

Guidotti co-founded Positive Exposure in 1997 with the aim of capturing the inherent beauty of people with physical afflictions like albinism, Down syndrome, Marfan syndrome, a connective tissue disorder, and Sturge-Weber syndrome, a disorder that results in port-wine stain birthmarks on the face.

'The idea is to walk away with a new understanding of beauty,' Guidotti said.

Several of Guidotti’s photographs adorn the walls of the VSA arts of Colorado/Access Gallery studio at 909 Santa Fe Drive in Denver.

The people depicted in the photographs hail from all over the globe, including Africa, New Zealand, Australia, Malaysia, Canada, New York and Washington DC..."

Link to the article

Denver Life Science Cluster Ranks 12th In U.S. - New Jones Lang LaSalle Report

noreply@blogger.com (Maggie Chamberlin Holben, APR) — Fri, 02 Dec 2011 15:21:00 +0000

Jones Lang LaSalle has released its 2011 Global Life Sciences Cluster Report. The Denver Market ranks 12th overall in the U.S. and is considered an emerging market.

According to the report overview:

"As life science companies determine which aspects of the business are vital to drug discovery and innovation, they are bifurcating their location strategies to optimize the cost versus output equation.

Established clusters within the United States and Europe remain destinations of choice for core aspects of drug discovery. Companies are able to offset the high costs of operating in established clusters with the increased odds of innovation due to deep, rich talent pools and infrastructure. Emerging global clusters, however, offer cost-advantageous manufacturing sites that provide both revenue and margin opportunities. Additionally, emerging clusters are becoming more competitive in hightech aspects of the value chain, due to significant capital investments
and improved political policies."

Link to the report pdf

Video: Senator Bennet Urges FDA to Provide More Regulatory Certainty to Spark Investments in Colorado Medical Device Industry

noreply@blogger.com (Maggie Chamberlin Holben, APR) — Thu, 17 Nov 2011 12:28:00 +0000

"Colorado U.S. Senator Michael Bennet yesterday urged the Food and Drug Administration (FDA) to continue building on efforts to provide more regulatory certainty and remove red tape to unleash much-needed investment in job-creating bioscience innovations in Colorado and the entire country. Bennet wants to work with the FDA to encourage faster approvals of safe and effective lifesaving products, so they get to the patients who need them most more quickly.

At a Senate Committee on Health, Education, Labor and Pensions hearing, Bennet questioned Dr. Jeffrey E. Shuren, director of the Center for Devices and Radiological Health at the FDA, about how the FDA can modernize and reposition itself as a driver of global innovation in the 21st century. Bennet has introduced a bill, along with Senators Richard Burr (R-NC) and Amy Klobuchar (D-MN) to provide more certainty and reduce unnecessary regulatory roadblocks for the medical device sector, while maintaining a commitment to safety, so patients receive innovative products faster.

In October, Bennet joined the National Venture Capital Association’s MedIC Coalition at the release of a survey of more than 150 venture capital firms that showed that U.S. venture capitalists are decreasing their investments in biopharmaceutical and medical device companies, reducing their concentration in prevalent disease areas and shifting investment away from the United States towards Europe and Asia."

http://youtu.be/8ojllUQTEV8

Link to the CBSA Online Posting

Photo Exhibit By Colorado Bioscience Awards Keynote Rick Guidotti Opens 11/18 At Santa Fe Arts District VSA Colorado/Access Gallery

noreply@blogger.com (Maggie Chamberlin Holben, APR) — Mon, 14 Nov 2011 20:38:00 +0000

Photos by Colorado BioScience Association (CBSA) Awards Dinner Keynote Speaker Rick Guidotti will be on display for the general public beginning November 18 (through December 16) at the VSA Colorado/Access Gallery in Denver's Santa Fe Arts District. The announcement is made by Holli Riebel, CBSA President and CEO, who says: “We are very pleased that everyone in the community will have the opportunity to see Rick's powerful images about genetic difference."

View a video about Rick Guidotti's Positive Exposure and its mission:

http://youtu.be/_-cMu3UA4QE

Link to the Business Wire Release

Link to the Pitch Engine Social Media Newswire

CBSA Launches Internship Program With Support of 11 Employers + Area Universities

noreply@blogger.com (Maggie Chamberlin Holben, APR) — Wed, 09 Nov 2011 17:48:00 +0000

The CBSA is launching its new Internship Program with the support of 11 founding employers in the Denver area. The announcement is made by Holli Riebel, CBSA President and CEO, who says: “Our education committee has been working diligently with our member companies and universities for the past six months to develop a program that will be valuable to both the student interns and participating companies as we go forward. We will begin intern recruitment immediately through early spring 2012 with the first interns expected to be placed in positions by summer 2012."

Participating employers, at program launch, include:

* Allosource
* Amgen
* Baxa Corporation
* CaridianBCT, Becoming TerumoBCT
* Colorado BioScience Association
* Colorado Institute for Drug, Device and Diagnostic Development (CID4)
* GlobeImmune
* Merck
* Sandhill Scientific
* Sharklet Technologies
* Tolmar

"In addition to these 'founding employers,' we've had interest from yet another six companies. Our team has been very pleased with the positive response from both employers and our universities," Mark Spiecker, President & CEO of Sharklet Technologies and Chair of the CBSA Education Committee, explains. "Now more than ever, there's an extreme need for university students to obtain real world experience, in addition to their time in the classroom."

Link to the Business Wire Release

Link to the Pitch Engine Social Media Release

Ariel Pharma Only Colorado Life Science Company Presenting at Prestigious Silicon Valley Bank SVB Showcase Event

noreply@blogger.com (Maggie Chamberlin Holben, APR) — Thu, 03 Nov 2011 15:08:00 +0000

CBSA Board Chair Steve Orndorff, President & CEO of Ariel Pharmaceuticals, presented at Silicon Valley Bank's SVB Showcase, October 20 in Menlo Park, CA. Ariel was the only life science company from Colorado presenting to more than 200 investors at the conference. SVB Showcase 2011, hosted by the SVB Accelerator, featured three concurrent tracks with presentations from companies seeking a Series A, B or C round of financing in the life science, cleantech and technology sectors.

Here's video of Orndorff's SVB Showcase interview about Ariel Pharma:

http://youtu.be/iBqeHnRGvG0

Link to the Ariel Pharmaceuticals website

Link to the SVB - Silicon Valley Bank website

Interview: ValveXchange's Larry Blankenship and Dr. Ivan Vesely

noreply@blogger.com (Maggie Chamberlin Holben, APR) — Mon, 31 Oct 2011 16:38:00 +0000

w3w3's Larry Nelson:

"We're talking with Larry Blankenship, Chairman of the Board and CEO of ValveXchange and Ivan Vesely, Founder and Chief Science Officer. Dr. Vesely is a PhD. Bio Physicist who founded the company and invented this heart valve technology." Link to the w3w3.com interview

ValveXchange recently announced its successful First in Man procedures. Link to the related Business Wire release.